1. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate‐to‐severe plaque‐type psoriasis patients treated with infliximab in routine care settings of Greece. (20th April 2018) Authors: Petridis, A.; Panagakis, P.; Moustou, E.; Vergou, T.; Kallidis, P.; Mandekou‐Lefaki, I.; Chaidemenos, G.; Sotiriadis, D.; Alexopoulou, G.; Haratsis, Y.; Antoniou, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 5(2018) Page Start: 768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patient preference study for different characteristics of systemic psoriasis treatments (Protimisis). Issue 3 (6th February 2018) Authors: Rigopoulos, D.; Ioannides, D.; Chaidemenos, G.; Kallidis, P.; Voultsidou, A.; Matekovits, A.; Soura, E. Journal: Dermatologic therapy Issue: Volume 31:Issue 3(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗